ArticleInternational journal of hematology2026
Dasatinib is superior to imatinib in adult Ph + ALL: a propensity score-matched analysis of pooled JALSG trial data.
Satoshi Nishiwaki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it